Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast
Creators
- 1. Department of Biochemistry, All India Institute of Medical Sciences, New Delhi (India)
- 2. Department of Anatomy, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi (India)
- 3. Department of Pathology, All India Institute of Medical Sciences, New Delhi (India)
- 4. Department of Surgery, Vardhman Mahavir Medical College and Safdarjung Hospital, New Dehi (India)
- 5. Department of Surgery, All India Institute of Medical Sciences, New Delhi -110029 (India)
- 6. Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, M5G 2N2 (Canada)
- 7. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Room 6-500, Toronto, Ontario M5G 1X5 (Canada)
- 8. Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, 600 University Avenue, Room 6-500, Toronto, Ontario M5G 1X5 (Canada)
- 9. Sonshine Family Centre for Head & Neck Disease, Mount Sinai Hospital, 600 University Avenue, Room 6-500, Toronto, Ontario M5G 1X5 (Canada)
Description
Cancer progression is linked to a partially dedifferentiated epithelial cell phenotype. The signaling pathways Wnt, Hedgehog, TGF-β and Notch have been implicated in experimental and developmental epithelial mesenchymal transition (EMT). Recent findings from our laboratory confirm that active Wnt/β-catenin signaling is critically involved in invasive ductal carcinomas (IDCs) of breast. In the current study, we analyzed the expression patterns and relationships between the key Wnt/β-catenin signaling components- E-cadherin, Slug and GSK3β in IDCs of breast. Of the 98 IDCs analyzed, 53 (54%) showed loss/or reduced membranous staining of E-cadherin in tumor cells. Nuclear accumulation of Slug was observed in 33 (34%) IDCs examined. Loss or reduced level of cytoplasmic GSK3β expression was observed in 52/98 (53%) cases; while 34/98 (35%) tumors showed nuclear accumulation of GSK3β. Statistical analysis revealed associations of nuclear Slug expression with loss of membranous E-cadherin (p = 0.001); nuclear β-catenin (p = 0.001), and cytoplasmic β-catenin (p = 0.005), suggesting Slug mediated E-cadherin suppression via the activation of Wnt/β-catenin signaling pathway in IDCs. Our study also demonstrated significant correlation between GSK3β nuclear localization and tumor grade (p = 0.02), suggesting its association with tumor progression. The present study for the first time provided the clinical evidence in support of Wnt/β-catenin signaling upregulation in IDCs and key components of this pathway - E-cadherin, Slug and GSK3β with β-catenin in implementing EMT in these cells
Availability note (English)
Available from http://dx.doi.org/10.1186/1471-2407-9-325; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753637Additional details
Identifiers
Publishing Information
- Journal Title
- BMC Cancer (Online)
- Journal Volume
- 9
- Journal Page Range
- p. 325
- ISSN
- 1471-2407
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46092366
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BUILDUP; CARCINOMAS; CORRELATIONS; INHIBITION; MAMMARY GLANDS; NOTCHES; PHENOTYPE
- Descriptors DEC
- BODY; DISEASES; GLANDS; NEOPLASMS; ORGANS
Optional Information
- Copyright
- Copyright (c)2009 Prasad et al
- Notes
- PMCID: PMC2753637; PUBLISHER-ID: 1471-2407-9-325; PMID: 19751508; OAI: oai:pubmedcentral.nih.gov:2753637; licensee BioMed Central Ltd.